deltatrials
Unknown PHASE1 INTERVENTIONAL 6-arm NCT02870036

Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics of Simmitecan Monotherapy and Combination in Patients With Advanced Solid Tumors

Sponsor: Haihe Biopharma Co., Ltd.

Conditions Advanced Solid Tumor Advanced/Metastatic Colorectal Cancer
Interventions 5-fluorouracil and Leucovorin Calcium Simmitecan Thalidomide
Updated 8 times since 2017 Last updated: Jul 11, 2017 Started: Oct 31, 2016 Primary completion: Dec 31, 2020 Completion: Dec 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02870036, this PHASE1 trial focuses on Advanced Solid Tumor and Advanced/Metastatic Colorectal Cancer and remains ongoing. Sponsored by Haihe Biopharma Co., Ltd., it has been updated 8 times since 2016, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshotNot Yet Recruiting~Apr 2017 – ~Aug 2017 · 4 months · monthly snapshotRecruiting~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotUnknown Status~Oct 2021 – ~Jul 2024 · 33 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 23 months · monthly snapshotUnknown

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1

    Status: Unknown Status → Unknown

  3. Oct 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1

  4. Jan 2021 — Oct 2021 [monthly]

    Unknown Status PHASE1

    Status: Recruiting → Unknown Status

  5. Jun 2018 — Jan 2021 [monthly]

    Recruiting PHASE1

▶ Show 3 earlier versions

  1. Aug 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

  2. Apr 2017 — Aug 2017 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  3. Jan 2017 — Apr 2017 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Haihe Biopharma Co., Ltd.
Data source: Haihe Biopharma Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations